Used in biomedical research to detect and quantify EPHA1 protein levels in human liver tissue or serum samples. Helps in studying liver diseases, including hepatocellular carcinoma and cirrhosis, by measuring receptor expression changes. Supports investigation into cell signaling pathways involved in liver regeneration and tumor progression. Commonly applied in academic research, drug development, and clinical diagnostics to assess EPHA1 as a potential biomarker. Enables high-throughput screening in experimental models evaluating therapeutic targets related to hepatic function and disease.